Decisions of the Extraordinary General Meeting of Biohit Oyj
Biohit Oyj Decisions of the Extraordinary General Meeting 16, 2018 at 17.00 local time (EET)
Resolution on the increase the size of the Board of Directors
The Extraordinary General Meeting (EGM) of Biohit Oyj held on Thursday August 16, 2018 decided to accept the propose to increase the number of Board members.
The number shall be six (6).
Election of new member of the Board of Directors
Shareholders of Biohit Oyj, who represent more than 50% of the voting rights of the company’s shares, decided that Managing Director of Biohit HealthCare (Hefei) Co., Ltd Liu Feng is elected as new member until the end of the next Annual General Meeting on addition of the Board members, which were elected in Annual General Meeting.
More information on the new member is available on the company website at: www.biohit.fi/sijoittajat.
All decisions of the EGM were made unanimously. The minutes of the EGM will be available for review by shareholders by August 21, 2018 on the company’s website (www.biohithealthcare.com /investors) and at the corporate headquarters of Biohit, located at Laippatie 1, 00880 Helsinki.
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com